J 2023

Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2

SAMEC, Marek, Alena MAZURAKOVA, Vincent LUCANSKY, Lenka KOKLESOVA, Renata PECOVA et. al.

Základní údaje

Originální název

Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2

Autoři

SAMEC, Marek, Alena MAZURAKOVA, Vincent LUCANSKY, Lenka KOKLESOVA, Renata PECOVA, Martin PEC, Olga GOLUBNITSCHAJA, Raghad Khalid AL-ISHAQ, Martin CAPRNDA, Ludovit GASPAR, Robert PROSECKÝ (203 Česká republika, domácí), Katarina GAZDIKOVA, Mariusz ADAMEK, Dietrich BUESSELBERG, Peter KRUŽLIAK (703 Slovensko, garant, domácí) a Peter KUBATKA

Vydání

European Journal of Pharmacology, AMSTERDAM, Elsevier, 2023, 0014-2999

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 5.000 v roce 2022

Kód RIV

RIV/00216224:14110/23:00131597

Organizační jednotka

Lékařská fakulta

UT WoS

001053815500001

Klíčová slova anglicky

Flavonoids; Cancer cells; Carcinogenesis; Metabolism; Metabolic reprogramming

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 5. 9. 2023 10:47, Mgr. Tereza Miškechová

Anotace

V originále

Metabolic reprogramming of cancer cells is a common hallmark of malignant transformation. The preference for aerobic glycolysis over oxidative phosphorylation in tumors is a well-studied phenomenon known as the Warburg effect. Importantly, metabolic transformation of cancer cells also involves alterations in signaling cascades contributing to lipid metabolism, amino acid flux and synthesis, and utilization of ketone bodies. Also, redox regulation interacts with metabolic reprogramming during malignant transformation. Flavonoids, widely distributed phytochemicals in plants, exert various beneficial effects on human health through modulating molecular cascades altered in the pathological cancer phenotype. Recent evidence has identified numerous flavonoids as modulators of critical components of cancer metabolism and associated pathways interacting with metabolic cascades such as redox balance. Flavonoids affect lipid metabolism by regulating fatty acid synthase, redox balance by modulating nuclear factor-erythroid factor 2-related factor 2 (Nrf2) activity, or amino acid flux and synthesis by phosphoglycerate mutase 1. Here, we discuss recent preclinical evidence evaluating the impact of flavonoids on cancer metabolism, focusing on lipid and amino acid metabolic cascades, redox balance, and ketone bodies.